Peter Sadow, MD, Pathology, Boston, MA, Massachusetts Eye and Ear


Pathology Boston, MA

Anatomic Pathology, Surgical Pathology

Pathologist, Massachusetts General Hospital; Associate Professor of Pathology, Harvard Medical School

Dr. Sadow is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sadow's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalRESIDENCY
  • University of Chicago Pritzker School of Medicine
    University of Chicago Pritzker School of MedicineMEDICAL_SCHOOL
  • University of Chicago
    University of ChicagoOTHER_TRAINING
  • Johns Hopkins University
    Johns Hopkins UniversityOTHER_TRAINING

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2007 - 2022
  • American Board of Pathology Pathology - Anatomic

Awards, Honors, & Recognition

  • Teacher of the Year, Anatomic Pathology MGH Pathology

Publications & Presentations


Journal Articles

  • [18F]Fluorocholine and [18F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM  
    Peter Sadow, MD, Clinical Cancer Research


  • Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis 
    Harvard Medical School, Boston, Massachusetts - 6/15/2012
  • Current Concepts in Head and Neck & Endocrine Pathology 
    Harvard Medical School - Fairmont Copley Plaza - 6/3/2015

Press Mentions

  • Veracyte to Launch New Afirma Xpression Atlas and Present Platform Performance Data at AACE 2018 Meeting
    Veracyte to Launch New Afirma Xpression Atlas and Present Platform Performance Data at AACE 2018 MeetingMay 16, 2018

Grant Support

  • Strategies to Overcome Immune Resistance in Head and Neck CancersNIH/NCI2019–2024
  • Optimization of Treatment of Thyroid Nodules: A Personalized ApproachNIH/NCI2019–2024
  • High Grade Transformation in Salivary Gland CarcinomasMassachusetts General Hospital (Colvin-Vickery Fund)2020–2021

Professional Memberships

Hospital Affiliations